Issue 3, 2010
Satellite Symposium Reports
- From protein to pharmacy: the role of biosimilars
- Preventing occupational exposures to cytotoxic drugs in hospital pharmacies
- Using innovation to develop vital therapies for patients: pursuing the answer to key questions
- The evolving role of the pharmacist - how can the pharmacists drive medication error prevention
Industry Science
- Modelling the net resource implications and budget impact of using generic docetaxel instead of branded docetaxel in Spain
- Retacrit® (epoetin zeta) is the first biosimilar epoetin to achieve a subcutaneous licence in renal anaemia
- New formulation Taxodere® reduce preparation time and support the physical stability of the product in infusion bags: data from the RELIUS international observational study
